PRESS RELEASE published on 11/21/2025 at 01:30, 2 months 14 days ago Onco-Innovations Advances Optimization and Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services to Support Future Phase 1 Clinical Studies Onco-Innovations partners with Dalton Pharma Services for A83B4C63 manufacturing optimization and scale-up activities, aiming for future clinical material production Onco-Innovations Dalton Pharma Services Manufacturing Optimization Scale-up Activities Clinical Material Production
BRIEF published on 11/19/2025 at 00:05, 2 months 16 days ago Onco-Innovations and Kuano Collaborate on PNKP Inhibitor Development AI In Drug Discovery Onco-Innovations PNKP Inhibitor Kuano Quantum Analytics
BRIEF published on 11/19/2025 at 00:05, 2 months 16 days ago Onco-Innovations et Kuano collaborent au développement d'un inhibiteur de PNKP L'IA Dans La Découverte De Médicaments Onco-Innovations Inhibiteur De PNKP Kuano Analyse Quantique
PRESS RELEASE published on 11/19/2025 at 00:00, 2 months 16 days ago Onco-Innovations Advances AI and Quantum Drug Discovery with Kuano Collaboration to Accelerate PNKP Inhibitor Technology Development Onco-Innovations partners with Kuano Ltd. to accelerate development of PNKP Inhibitor Technology, leveraging quantum analytics for cancer therapeutics. Details on advanced collaboration Cancer Therapeutics Onco-Innovations Quantum Analytics Kuano Ltd. PNKP Inhibitor Technology
BRIEF published on 11/08/2025 at 00:05, 2 months 27 days ago Inka Health d'Onco-Innovations améliore l'utilisation des données médicales à l'échelle mondiale Oncologie Maladies Rares Technologies De La Santé Preuves Issues Du Monde Réel Portabilité Des Données
BRIEF published on 11/08/2025 at 00:05, 2 months 27 days ago Onco-Innovations' Inka Health Enhances Global Medical Data Use Health Technology Oncology Real-world Evidence Rare Diseases Data Transportability
PRESS RELEASE published on 11/08/2025 at 00:00, 2 months 27 days ago Onco-Innovations' Inka Health Publishes Framework on Transportability of Real-World Evidence and Use in Health Technology Assessment Onco-Innovations Limited's subsidiary, Inka Health Corp., publishes primer on transportability of real-world evidence in oncology, outlining key statistical methods and potential impact on rare disease drug approvals Oncology Real-world Evidence Rare Diseases Onco-Innovations Limited Inka Health Corp.
BRIEF published on 10/31/2025 at 23:05, 3 months 4 days ago Onco-Innovations poursuit une croissance stratégique aux États-Unis suite à l'intérêt des investisseurs. Essais Cliniques Relations Avec Les Investisseurs Traitement Du Cancer Onco-Innovations Stratégie Américaine
BRIEF published on 10/31/2025 at 23:05, 3 months 4 days ago Onco-Innovations Pursues Strategic U.S. Growth Following Investor Spotlight Investor Relations Clinical Trials Cancer Treatment Onco-Innovations U.S. Strategy
PRESS RELEASE published on 10/31/2025 at 23:00, 3 months 4 days ago Onco-Innovations Provides Shareholder Update Following Cboe Canada Investor Spotlight Onco-Innovations Limited updates strategic objectives focusing on U.S. strategy, including plans for clinical trials, U.S. stock exchange listing, and growth initiatives Clinical Trials Stock Exchange Listing Growth Initiatives Onco-Innovations Limited U.S. Strategy
Published on 02/05/2026 at 01:35, 4 hours 36 minutes ago Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Published on 02/05/2026 at 00:00, 6 hours 11 minutes ago Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/04/2026 at 22:25, 7 hours 46 minutes ago 55 North Mining Announces Flow-Through Financing
Published on 02/04/2026 at 16:15, 13 hours 56 minutes ago Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures
Published on 02/04/2026 at 20:54, 9 hours 17 minutes ago Elmos Semiconductor SE is planning to distribute 36 million Euro to shareholders for the fiscal year 2025
Published on 02/04/2026 at 20:36, 9 hours 35 minutes ago EQS-Adhoc: Elmos Semiconductor SE approves share buyback program via the stock exchange of 10 million Euro and dividend proposal of 1.50 Euro per share for fiscal year 2025
Published on 02/04/2026 at 20:00, 10 hours 10 minutes ago Belgium's Ingmar De Vos elected to Executive Board of International Olympic Committee
Published on 02/04/2026 at 18:55, 11 hours 16 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/04/2026 at 18:40, 11 hours 30 minutes ago Robin Zeng: Unlocking the Sustainable Energy Era with Zero-Carbon Technology
Published on 02/04/2026 at 18:04, 12 hours 7 minutes ago Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 12 hours 7 minutes ago Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 12 hours 26 minutes ago Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 12 hours 26 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL